High costs, low adherence: The GLP-1 challenge for managed care

Medicaid spending on GLP-1s has surged by 500% since 2019, with annual per-patient costs topping $17,000. Yet just one in three patients stay on these medications after a year. As demand soars, payer leaders face urgent questions about affordability, adherence, and equitable access.

To ensure the sustainable implementation of GLP-1s, managed care organizations must adopt innovative strategies, such as value-based contracting and comprehensive patient-engagement programs.

This report offers an evidence-based look at what GLP-1s mean for managed care — covering policy, pricing, and practical strategies for payer organizations.
What you’ll learn:

Key cost drivers and real-world adherence challenges
Proven approaches to utilization management and risk mitigation
Policy shifts and future trends shaping GLP-1 access and coverage

Please fill out the form to download the whitepaper.

Download the Whitepaper

Please enable JavaScript in your browser to complete this form.

First Name

Last Name

Work Email

Job Title

Company Name

State

employed Name Job

What type of institution are you employed by?

Sign me up for Becker's Hospital Review E-Weekly.Read by over 450,000 healthcare professionals.

a (copy)

I accept that the data provided on this form will be processed, stored, and used in accordance with the terms set out in Techwaves privacy policy.

By registering, you agree to Becker's Healthcare terms of services and privacy policy.

High costs, low adherence: The GLP-1 challenge for managed care

Download the Whitepaper

Don’t miss a Single Article!